NasdaqCM - Delayed Quote USD

Clearmind Medicine Inc. (CMND)

1.0325 -0.0075 (-0.72%)
At close: June 7 at 4:00 PM EDT
1.0400 +0.01 (+0.73%)
After hours: June 7 at 5:40 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
10/31/2023
10/31/2022
10/31/2021
10/31/2020
10/31/2019
Operating Expense
4,108.8953
4,557.9623
4,593.4993
2,173.3388
175.0585
--
Operating Income
-4,108.8953
-4,557.9623
-4,593.4993
-2,173.3388
-175.0585
--
Net Non Operating Interest Income Expense
85.3492
42.7882
-10.5935
--
--
--
Other Income Expense
-1,467.7641
-1,705.9221
-440.2585
-25.7333
-134.8773
--
Pretax Income
-5,491.3102
-6,221.0962
-5,044.3513
-2,199.0720
-309.9359
--
Tax Provision
210.6786
12.5616
21.9401
--
--
--
Net Income Common Stockholders
-5,701.9888
-6,233.6578
-5,066.2914
-2,199.0720
-309.9359
--
Diluted NI Available to Com Stockholders
-5,701.9888
-6,233.6578
-5,066.2914
-2,199.0720
-309.9359
--
Basic EPS
-6.89
-30.79
-116.91
-71.14
-17.11
--
Diluted EPS
-6.89
-30.79
-116.91
-71.14
-17.11
--
Basic Average Shares
562.6970
202.4800
43.3340
30.9100
18.1300
--
Diluted Average Shares
562.6970
202.4800
43.3340
30.9100
18.1300
--
Rent Expense Supplemental
--
--
--
--
9.0824
22.7841
Total Expenses
4,108.8953
4,557.9623
4,593.4993
2,173.3388
175.0585
--
Net Income from Continuing & Discontinued Operation
-5,701.9888
-6,233.6578
-5,066.2914
-2,199.0720
-309.9359
--
Normalized Income
-4,821.3303
-5,210.1045
-4,741.4247
-2,173.3388
-175.0585
--
Interest Expense
--
--
14.4592
--
--
--
Net Interest Income
85.3492
42.7882
-10.5935
--
--
--
EBIT
-4,108.8953
-4,557.9623
-4,593.4993
-2,173.3388
-309.9359
--
EBITDA
-4,080.6733
-4,516.3773
-4,532.4624
-2,171.8169
-309.9359
--
Reconciled Depreciation
28.2220
41.5850
61.0369
1.5202
--
--
Net Income from Continuing Operation Net Minority Interest
-5,701.9888
-6,233.6578
-5,066.2914
-2,199.0720
-309.9359
--
Total Unusual Items Excluding Goodwill
-1,467.7641
-1,705.9221
-440.2585
-25.7333
-134.8773
--
Total Unusual Items
-1,467.7641
-1,705.9221
-440.2585
-25.7333
-134.8773
--
Normalized EBITDA
-2,612.9092
-2,810.4552
-4,092.2039
-2,146.0836
-175.0585
--
Tax Rate for Calcs
0.0004
0.0004
0.0003
--
--
--
Tax Effect of Unusual Items
-587.1056
-682.3688
-115.3918
--
--
--
10/31/2019 - 11/15/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SPRC SciSparc Ltd.
0.8990
-4.61%
 
PXMD PaxMedica, Inc.
0.3120
-5.45%
 
OKYO OKYO Pharma Limited
1.2700
-9.93%
 
CDIO Cardio Diagnostics Holdings, Inc.
0.6774
-0.59%
 
AZTR Azitra, Inc.
0.1496
-9.39%
 
ZVSA ZyVersa Therapeutics, Inc.
4.4100
-6.96%
 
NEXI NexImmune, Inc.
3.0000
-5.36%
 
SONN Sonnet BioTherapeutics Holdings, Inc.
1.7000
+2.41%
 
NRBO NeuroBo Pharmaceuticals, Inc.
3.9300
-1.26%
 
PHIO Phio Pharmaceuticals Corp.
0.7450
+0.95%